W M Kast - JoVE Visualize

Showing results (41-50 of 128) with videos related to

Pageof 13

Sort By:

Archives of Virology|September 11, 1999

Differences in the effectiveness of delivery of B- and CTL-epitopes incorporated into the hepatitis B core antigen (HBcAg) c/e1-regionM Street, K Herd, P Londono, et al.

Current Opinion in Molecular Therapeutics|March 16, 2001

Papillomavirus virus-like particles as anticancer vaccinesD M Da Silva, M P Velders, M P Rudolf, et al.

European Journal of Immunology|February 1, 1990

Induction of transplantation tolerance by intravenous injection of allogeneic lymphocytes across an H-2 class II mismatch. Different mechanisms operate in tolerization across an H-2 class I vs. H-2 class II disparityE van Twuyver, W M Kast, R J Mooijaart, et al.

Human Immunology|November 1, 1990

Different requirements for the regulation of transplantation tolerance induction for allogeneic versus xenogeneic major histocompatibility complex antigensE van Twuyver, R J Mooijaart, W M Kast, et al.

International Journal of Cancer|May 29, 1996

Efficient tumor eradication by adoptively transferred cytotoxic T-cell clones in allogeneic hostsR E Toes, W M Kast, R J Blom, et al.

Cancer Surveys|January 1, 1995

Class I MHC-peptide interactions: structural requirements and functional implicationsH M Grey, J Ruppert, A Vitiello, et al.

Transplantation|November 27, 1996

Peptide specificity of alloreactive CD4 positive T lymphocytes directed against a major histocompatibility complex class I disparityM A Ossevoort, M L De Bruijn, K J Van Veen, et al.

Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1996

Immunogenicity of peptides bound to MHC class I molecules depends on the MHC-peptide complex stabilityS H van der Burg, M J Visseren, R M Brandt, et al.

Cell|August 10, 1990

Direct binding of peptide to empty MHC class I molecules on intact cells and in vitroT N Schumacher, M T Heemels, J J Neefjes, et al.

Cancer Research|August 15, 1996

Protective antitumor immunity induced by immunization with completely allogeneic tumor cellsR E Toes, R J Blom, E van der Voort, et al.

Pageof 13

Showing results (41-50 of 128) with videos related to

Sort By:

Pageof 13

Archives of Virology|September 11, 1999

Differences in the effectiveness of delivery of B- and CTL-epitopes incorporated into the hepatitis B core antigen (HBcAg) c/e1-regionM Street, K Herd, P Londono, et al.

Current Opinion in Molecular Therapeutics|March 16, 2001

Papillomavirus virus-like particles as anticancer vaccinesD M Da Silva, M P Velders, M P Rudolf, et al.

European Journal of Immunology|February 1, 1990

Induction of transplantation tolerance by intravenous injection of allogeneic lymphocytes across an H-2 class II mismatch. Different mechanisms operate in tolerization across an H-2 class I vs. H-2 class II disparityE van Twuyver, W M Kast, R J Mooijaart, et al.

Human Immunology|November 1, 1990

Different requirements for the regulation of transplantation tolerance induction for allogeneic versus xenogeneic major histocompatibility complex antigensE van Twuyver, R J Mooijaart, W M Kast, et al.

International Journal of Cancer|May 29, 1996

Efficient tumor eradication by adoptively transferred cytotoxic T-cell clones in allogeneic hostsR E Toes, W M Kast, R J Blom, et al.

Cancer Surveys|January 1, 1995

Class I MHC-peptide interactions: structural requirements and functional implicationsH M Grey, J Ruppert, A Vitiello, et al.

Transplantation|November 27, 1996

Peptide specificity of alloreactive CD4 positive T lymphocytes directed against a major histocompatibility complex class I disparityM A Ossevoort, M L De Bruijn, K J Van Veen, et al.

Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1996

Immunogenicity of peptides bound to MHC class I molecules depends on the MHC-peptide complex stabilityS H van der Burg, M J Visseren, R M Brandt, et al.

Cell|August 10, 1990

Direct binding of peptide to empty MHC class I molecules on intact cells and in vitroT N Schumacher, M T Heemels, J J Neefjes, et al.

Cancer Research|August 15, 1996

Protective antitumor immunity induced by immunization with completely allogeneic tumor cellsR E Toes, R J Blom, E van der Voort, et al.

Pageof 13